Amikacin Dosing and Route of Administration
Amikacin should be administered intravenously (IV) or intramuscularly (IM) at a dose of 15 mg/kg once daily for adults, with a maximum of 1 gram per day, and 15-30 mg/kg once daily for children, with a maximum of 1 gram per day. 1, 2, 1
Standard Dosing Regimens
Adults
- Standard dose: 15 mg/kg/day IV or IM, typically given as a single daily dose (5-7 days/week initially) 1, 2, 1
- Maximum daily dose: 1 gram/day (some sources allow up to 1.5 g/day in heavier patients) 3
- Alternative regimen: 7.5 mg/kg every 12 hours OR 5 mg/kg every 8 hours 3
- Age adjustment: For patients >59 years, reduce to 10 mg/kg/day (750 mg maximum) 1, 2
Children
- Standard dose: 15-30 mg/kg/day IV or IM as a single daily dose 1, 2, 1
- Maximum: 1 gram/day 1, 2
- Newborns: Loading dose of 10 mg/kg, followed by 7.5 mg/kg every 12 hours 3
Route of Administration
Both IV and IM routes are acceptable 1, 2, 1, 3. For IV administration:
- Infuse over 30-60 minutes in adults 3
- Infuse over 30-60 minutes in pediatric patients 3
- Infuse over 1-2 hours in infants 3
Special Populations and Dosing Adjustments
Renal Impairment
Critical consideration: Amikacin clearance is almost exclusively renal, requiring mandatory dose adjustments 1, 2, 1. Two approaches are available:
Extended interval dosing (preferred): Maintain the 12-15 mg/kg dose but reduce frequency to 2-3 times per week to leverage concentration-dependent bactericidal effects 1, 2
Reduced dose at fixed intervals: Calculate maintenance dose proportional to creatinine clearance reduction 3
Practical adjustment: If creatinine clearance unavailable, multiply serum creatinine by 9 to determine dosing interval in hours (e.g., serum creatinine 2 mg/dL = dose every 18 hours) 3
Obesity
For markedly obese patients, use adjusted body weight: ideal body weight + 40% of excess weight 4
- Male IBW (kg) = 50 + (2.3 × height in cm above 152.4)/2.54
- Female IBW (kg) = 45.5 + (2.3 × height in cm above 152.4)/2.54
Specific Infections
Tuberculosis/NTM: 15 mg/kg/day (maximum 1 g) initially daily, then reduce to 2-3 times weekly after 2-4 months or culture conversion 1, 2, 1
Plague treatment: 15-20 mg/kg every 24 hours IV or IM 5
Uncomplicated UTI: 250 mg twice daily may be sufficient 3
Carbapenem-resistant Enterobacterales: 15 mg/kg/day IV once daily 6
Therapeutic Drug Monitoring
Essential for safety and efficacy 1, 2, 1:
Target Levels
- Peak concentration: 25-35 mg/L (daily dosing) or 65-80 mg/L (three times weekly dosing) 4
- Trough concentration: <5 mg/L (ideally <2.5 mg/L) 4, 3
- Avoid: Peak >35 mcg/mL and trough >10 mcg/mL 3
Monitoring Schedule
- Obtain peak level in first week 4
- Trough levels weekly for 4 weeks, then can reduce to biweekly when stable 4
- Peak sample: 60-120 minutes after infusion ends 4
- Trough sample: immediately before next dose 4
Safety Monitoring
Baseline Assessment
Ongoing Monitoring
- Renal function: Twice weekly during month 1, weekly during month 2, then biweekly 4
- Auditory/vestibular symptoms: Monthly questioning 1, 2, 1
- Repeat audiogram if symptoms of ototoxicity develop 1, 2, 1
Critical Safety Considerations
Nephrotoxicity: Amikacin may be more nephrotoxic than streptomycin 1, 2. Risk increases with:
- Elevated baseline creatinine 1, 2
- Higher cumulative doses 1, 2
- Concomitant nephrotoxic agents (especially vancomycin) 1, 2
Ototoxicity: Primarily causes hearing loss (less vestibular dysfunction than streptomycin) 1, 2. Risk increases with:
Pregnancy: Contraindicated due to risk of fetal nephrotoxicity and congenital hearing loss 1, 2, 1